boston.com Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Comments
Send your comments and tips to whitecoat@globe.com
Categories


Blogger
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Contributors
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
 Short White Coat blogger Jennifer Srygley
Week of: November 11
Week of: November 4
Week of: October 28
Week of: October 21
Week of: October 14
Week of: October 7

« Journal asks: After a patient dies, how do doctors deal with their emotions? | Main | Short White Coat: Learning my 'doctoring style' »

Thursday, September 27, 2007

Today's Globe: vaccine mercury, 'good' cholesterol, veterans care, DSS plan, MS drug, melanoma drug, Dr. Gherardo Gherardi

A mercury-based preservative once used in many vaccines does not raise the risk of neurological problems in children, concludes a large federal study that researchers say should reassure parents about the safety of shots their children received a decade or more ago. The study, however, did not examine autism - the developmental disorder that some critics blame on vaccines. A separate study due out in a year will look at that issue.

The amount of "good cholesterol" in the blood remains an important marker for heart disease regardless of how much "bad cholesterol" is lowered, researchers said yesterday.

A bill that would reconfigure the leadership of the Department of Social Services was criticized yesterday by union officials, who said the focus of improving child-protection efforts should be at the ground level, where they said social worker caseloads need to be reduced.

Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis.

A very early test of an experimental drug seemed to slow the spread of advanced melanoma in a small study, Synta Pharmaceuticals Corp. of Lexington reported in preliminary findings yesterday.

gherardi85%202.bmpDr. Gherardo "Zeke" Gherardi (left) of Wellesley, who taught pathology at Tufts Medical School, Boston-Bouve School of Physical Therapy at Northeastern and Boston University School of Medicine and was an associate pathologist at Framingham Union Hospital, died Sept. 6 in an automobile accident near Hearne, Texas, while visiting. He was 86.

http://www.boston.com/news/globe/obituaries/articles/2007/09/27/g_gherardi_pathologist_professor/

Posted by Elizabeth Cooney at 06:56 AM
Sponsored Links